# The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection

> **NCT04664049** · — · UNKNOWN · sponsor: **National Research Institute of Chinese Medicine, Ministry of Health and Welfare** · enrollment: 51000 (estimated)

## Conditions studied

- SARS-CoV-2
- Covid 19

## Interventions

- **DIETARY_SUPPLEMENT:** NRICM101

## Key facts

- **NCT ID:** NCT04664049
- **Lead sponsor:** National Research Institute of Chinese Medicine, Ministry of Health and Welfare
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-23
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 51000 (ESTIMATED)
- **Last updated:** 2021-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04664049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04664049, "The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04664049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*